Pular para o conteúdo

Notícias Mercados Tendências Análises Guias

Inteligência de mercado e educação financeira para quem quer entender antes de investir.

Explorar

Notícias
Tendências
Análises
Guias
Buscar

Investir

Melhores investimentos
Commodities
Ações
FIIs
Cripto

© 2026 Fynark. Todos os direitos reservados.

Portal de informação e educação. Nada aqui é recomendação de investimento.

BTC/USDT$83,327.59+1.36%ETH/USDT$2,475.59+2.81%XRP/USDT$1.35+3.25%SOL/USDT$107.89+3.19%PETR4R$ 57,20-1.38%VALE3R$ 66,24-0.18%ITUB4R$ 49,11+2.53%BBDC4R$ 20,78+3.38%BTC/USDT$83,327.59+1.36%ETH/USDT$2,475.59+2.81%XRP/USDT$1.35+3.25%SOL/USDT$107.89+3.19%PETR4R$ 57,20-1.38%VALE3R$ 66,24-0.18%ITUB4R$ 49,11+2.53%BBDC4R$ 20,78+3.38%

Ao vivo

Imports hold back US economic growth in Q2, but domestic demand robust - Reuters — Fynark

Notícias Global

Global

Imports hold back US economic growth in Q2, but domestic demand robust - Reuters

Imports hold back US economic growth in Q2, but domestic demand robust Reuters

30 DE JUL DE 2026Por Administrador FynarkFonte: Reuters

Imports hold back US economic growth in Q2, but domestic demand robust - Reuters

Imports hold back US economic growth in Q2, but domestic demand robust Reuters

Fonte original: https://news.google.com/rss/articles/CBMiqwFBVV95cUxObWh4Um5od3luS0pRM0hOYTNwN0Z4bElZWFBXVDRRdFFVT2FpejU4ZkQ3MTVuY3hYb1NpMVd4QXV4WFhFMFUwbTRCbGs2cGlPOW11LWUxdzFyRnU0a0cwZU02b0s5b012M0p3Y2prV25KT0RQd3BGZk52aWNlanFDSDh5UTRRUVYtc2lsSm1RWjM4MjlzMXFCcEVrVjNvYVNzN3pNTm1zU2ZpV1U?oc=5

Notícias relacionadas

SpaceX reports after the bell. Here's what options traders expect

Global · 20 DE OUT DE 2026

SpaceX reports after the bell. Here's what options traders expect

Jim Cramer's top 10 things to watch in the stock market Tuesday

Global · 20 DE OUT DE 2026

Jim Cramer's top 10 things to watch in the stock market Tuesday

Investors look to earnings to reset the bull market. The key level to watch on the S&P 500

Global · 20 DE OUT DE 2026

Investors look to earnings to reset the bull market. The key level to watch on the S&P 500

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Global · 20 DE OUT DE 2026

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis